Kevin Caliendo

Q: What is Kevin Caliendo's success rate?

Kevin Caliendo currently has a success rate of 84.90769386601066.

Q: What is the average return of Kevin Caliendo's calls?

Their stock ratings have generated an average return of 24.246549963542805.

UBS | Healthcare

Kevin Caliendo is an analyst from UBS specializing in the Healthcare sector. Ranked #1474 out of 4745 analysts, they have issued 52 stock ratings with a success rate of 84.91% and an average return of 24.25%.

Kevin Caliendo has a well-established track record, with 52 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 84.91% and an average return of 24.25%, underscoring their expertise and ability to identify winning opportunities for investors.

#1474

Out of 4745

Total Ratings

+84.91%

Success Rate

+24.25%

Average Return

Recent Ratings Analysis

SOLV

Buy

Jul 28, 2026

Target

$95.00

Current

$86.17

Performance

0.00%

Kevin Caliendo rated SOLV as Buy on Jul 28, 2026, setting a price target of 95. Shares have remained stable near 86.17, leaving the 95 target still in play.

HSIC

Hold

Jul 28, 2026

Target

$89.00

Current

$85.71

Performance

0.00%

On Jul 28, 2026, HSIC was given a Neutral rating by Kevin Caliendo, with a target price of 89. Market indecision, reflected in sideways trading near 85.71, supported the cautious call.

DGX

Hold

Jul 24, 2026

Target

$232.00

Current

$235.94

Performance

3.55%

DGX received a Neutral rating from Kevin Caliendo on Jul 24, 2026, aiming for 232. Shares remained flat at 235.94, aligning with the neutral rating.

CVS

Buy

Jul 24, 2026

Target

$122.00

Current

$109.34

Performance

1.49%

On Jul 24, 2026, Kevin Caliendo published a Buy outlook on CVS, with a target of 122. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 109.34.

CAH

Buy

Jul 20, 2026

Target

$274.00

Current

$232.51

Performance

2.99%

Kevin Caliendo on Jul 20, 2026 assigned CAH a Buy rating, with a price target of 274. The recommendation remains pending validation as shares consolidate around 232.51.

ACH

Hold

May 12, 2026

Target

$4.50

Current

$3.25

Performance

1.56%

On May 12, 2026, Kevin Caliendo reaffirmed ACH with a Neutral rating, targeting 4.5. The neutral call matched muted market action of 1.56%.

MCK

Buy

May 08, 2026

Target

$1050.00

Current

$889.50

Performance

20.84%

MCK was rated Buy by Kevin Caliendo on May 08, 2026, with a price objective of 1050. A bullish response from the market helped close the gap of 160.50 to the target.

COR

Buy

May 07, 2026

Target

$412.00

Current

$319.58

Performance

25.00%

On May 07, 2026, Kevin Caliendo initiated coverage on COR with a Buy rating and target of 412. The stock’s climb of 25.00% since the call highlights the foresight in the rating.

XRAY

Buy

May 07, 2026

Target

$17.00

Current

$13.49

Performance

23.08%

Kevin Caliendo issued a Buy recommendation for XRAY on May 07, 2026, price target set at 17. Investors following the Buy call captured upside momentum, with shares now at 13.49.

AHCO

Buy

May 06, 2026

Target

$14.00

Current

$11.22

Performance

-1.75%

On May 06, 2026, AHCO was evaluated by Kevin Caliendo, who gave a Buy rating and target of 14. So far, the Buy call awaits clearer momentum, with shares flat at 11.22.

EVH

Buy

Feb 26, 2026

Target

$10.00

Current

$3.74

Performance

12.65%

Kevin Caliendo rated EVH as Buy on Feb 26, 2026, setting a price target of 10. The call has proven timely, with shares rising 12.65% toward the price target of 10.

LFST

Buy

Feb 26, 2026

Target

$12.00

Current

$11.24

Performance

61.49%

On Feb 26, 2026, LFST was given a Buy rating by Kevin Caliendo, with a target price of 12. The stock rallied 61.49% after the rating, narrowing the gap to the target of 12 and validating the bullish stance.

MDLN

Buy

Feb 26, 2026

Target

$57.00

Current

$40.51

Performance

-17.14%

MDLN received a Buy rating from Kevin Caliendo on Feb 26, 2026, aiming for 57. The rating hasn’t played out as hoped, with the stock trading 17.14% below expectations.

ALGN

Hold

Feb 05, 2026

Target

$185.00

Current

$175.60

Performance

-0.01%

On Feb 05, 2026, Kevin Caliendo published a Neutral outlook on ALGN, with a target of 185. Sideways action left the Hold view intact, with no major move since 175.6.

NVST

Hold

Feb 03, 2026

Target

$25.00

Current

$26.96

Performance

17.68%

Kevin Caliendo on Feb 03, 2026 assigned NVST a Neutral rating, with a price target of 25. Shares outperformed expectations, climbing 17.68% despite the neutral view.

ALHC

Hold

Jan 14, 2026

Target

$21.00

Current

$18.43

Performance

-15.26%

On Jan 14, 2026, Kevin Caliendo reaffirmed ALHC with a Neutral rating, targeting 21. The Hold stance reflected market caution that was later justified.

GDRX

Hold

Nov 06, 2025

Target

$4.00

Current

$3.12

Performance

-1.27%

GDRX was rated Neutral by Kevin Caliendo on Nov 06, 2025, with a price objective of 4. Flat performance suggests the Hold view was reasonable.

OMI

Hold

Nov 03, 2025

Target

$4.00

Current

$2.68

Performance

-22.32%

On Nov 03, 2025, Kevin Caliendo initiated coverage on OMI with a Neutral rating and target of 4. The rating matched the stock’s inability to hold above 2.68.

UNH

Buy

Oct 29, 2025

Target

$430.00

Current

$428.79

Performance

20.70%

Kevin Caliendo issued a Buy recommendation for UNH on Oct 29, 2025, price target set at 430. Investors following the Buy call captured upside momentum, with shares now at 428.79.

LH

Buy

Oct 29, 2025

Target

$320.00

Current

$314.23

Performance

26.63%

On Oct 29, 2025, LH was evaluated by Kevin Caliendo, who gave a Buy rating and target of 320. This case illustrates how a timely bullish rating can translate into tangible gains of 26.63%.

MOH

Hold

Oct 24, 2025

Target

$170.00

Current

$200.34

Performance

22.67%

Kevin Caliendo rated MOH as Neutral on Oct 24, 2025, setting a price target of 170. Despite the Hold call, shares climbed 22.67% to 200.34, revealing unexpected momentum.

PINC

Hold

Sep 25, 2025

Target

$28.25

Current

$50.05

Performance

80.10%

On Sep 25, 2025, PINC was given a Neutral rating by Kevin Caliendo, with a target price of 28.25. The stock rallied from 50.0499 to 50.0499 after the Hold rating, surprising to the upside.

AMWL

Hold

May 08, 2025

Target

$9.00

Current

$11.09

Performance

59.34%

AMWL received a Neutral rating from Kevin Caliendo on May 08, 2025, aiming for 9. Investors saw gains of 59.34% that the cautious stance didn’t fully capture.

CI

Buy

Feb 03, 2025

Target

$390.00

Current

$301.06

Performance

2.94%

On Feb 03, 2025, Kevin Caliendo published a Buy outlook on CI, with a target of 390. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 301.06.

WBA

Hold

Oct 17, 2024

Target

$10.00

Current

$11.98

Performance

12.38%

Kevin Caliendo on Oct 17, 2024 assigned WBA a Neutral rating, with a price target of 10. Shares outperformed expectations, climbing 12.38% despite the neutral view.

HUM

Hold

Oct 04, 2024

Target

$250.00

Current

$388.71

Performance

61.94%

On Oct 04, 2024, Kevin Caliendo reaffirmed HUM with a Neutral rating, targeting 250. Market strength beyond 388.71 went further than the conservative outlook suggested.

Frequency Asked Questions

Who is Kevin Caliendo?

Kevin Caliendo is an analyst from UBS specializing in the Healthcare sector.

What is Kevin Caliendo's success rate?

Kevin Caliendo currently has a success rate of +84.91%.

How many ratings has Kevin Caliendo issued?

Kevin Caliendo has issued 52 stock ratings so far.

What is the average return of Kevin Caliendo's calls?

Their stock ratings have generated an average return of +24.25%.

What is Kevin Caliendo's ranking?

Kevin Caliendo is ranked #1474 out of 4745 analysts.

What types of ratings does Kevin Caliendo give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Kevin Caliendo?

You can follow Kevin Caliendo by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Kevin Caliendo?

Their latest rating was a Buy on SOLV issued on 2026-07-28.